Cheng X - Search Results

1

Synthesis of novel derivatives of 4-amino-3-(2-furyl)-5-mercapto-1,2,4-triazole as potential HIV-1 NNRTIs.

Wu J, Liu X, Cheng X, Cao Y, Wang D, Li Z, Xu W, Pannecouque C, Witvrouw M, De Clercq E. Wu J, et al. Among authors: cheng x. Molecules. 2007 Aug 22;12(8):2003-16. doi: 10.3390/12082003. Molecules. 2007. PMID: 17960101 Free PMC article.

2

Design, synthesis, and biological activities of novel Ligustrazine derivatives.

Cheng XC, Liu XY, Xu WF, Guo XL, Ou Y. Cheng XC, et al. Bioorg Med Chem. 2007 May 15;15(10):3315-20. doi: 10.1016/j.bmc.2007.03.033. Epub 2007 Mar 15. Bioorg Med Chem. 2007. PMID: 17383884

3

Role of sulfonamide group in matrix metalloproteinase inhibitors.

Cheng XC, Wang Q, Fang H, Xu WF. Cheng XC, et al. Curr Med Chem. 2008;15(4):368-73. doi: 10.2174/092986708783497300. Curr Med Chem. 2008. PMID: 18288991 Review.

4

Advances in matrix metalloproteinase inhibitors based on pyrrolidine scaffold.

Cheng XC, Wang Q, Fang H, Xu WF. Cheng XC, et al. Curr Med Chem. 2008;15(4):374-85. Curr Med Chem. 2008. PMID: 18288992 Review.

5

Advances in assays of matrix metalloproteinases (MMPs) and their inhibitors.

Cheng XC, Fang H, Xu WF. Cheng XC, et al. J Enzyme Inhib Med Chem. 2008 Apr;23(2):154-67. doi: 10.1080/14756360701511292. J Enzyme Inhib Med Chem. 2008. PMID: 18343899 Free article. Review.

6

Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.

Cheng XC, Wang Q, Fang H, Tang W, Xu WF. Cheng XC, et al. Eur J Med Chem. 2008 Oct;43(10):2130-9. doi: 10.1016/j.ejmech.2007.12.020. Epub 2007 Dec 31. Eur J Med Chem. 2008. PMID: 18362041

7

Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.

Cheng XC, Wang Q, Fang H, Tang W, Xu WF. Cheng XC, et al. Bioorg Med Chem. 2008 May 15;16(10):5398-404. doi: 10.1016/j.bmc.2008.04.027. Epub 2008 Apr 15. Bioorg Med Chem. 2008. PMID: 18440232

8

Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.

Cheng XC, Wang Q, Fang H, Tang W, Xu WF. Cheng XC, et al. Bioorg Med Chem. 2008 Sep 1;16(17):7932-8. doi: 10.1016/j.bmc.2008.07.073. Epub 2008 Jul 30. Bioorg Med Chem. 2008. PMID: 18718763

9

Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents.

Cheng XC, Liu XY, Xu WF, Guo XL, Zhang N, Song YN. Cheng XC, et al. Bioorg Med Chem. 2009 Apr 15;17(8):3018-24. doi: 10.1016/j.bmc.2009.03.012. Epub 2009 Mar 13. Bioorg Med Chem. 2009. PMID: 19329327

10

Mechanism of tetramethylpyrazine analogue CXC195 inhibition of hydrogen peroxide-induced apoptosis in human endothelial cells.

Ou Y, Dong X, Liu XY, Cheng XC, Cheng YN, Yu LG, Guo XL. Ou Y, et al. Among authors: cheng xc, cheng yn. Biol Pharm Bull. 2010;33(3):432-8. doi: 10.1248/bpb.33.432. Biol Pharm Bull. 2010. PMID: 20190405 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,046 results

Search Page

Filters